BX Swiss TOP 30 CHF

BX Swiss TOP 30 CHF handeln
1.373,25 PKT +2,46 PKT +0,18 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN SL0CLV

ISIN DE000SL0CLV3


Analysen zu BX Swiss TOP 30 CHF-Werten

Datum Rating Analyst
24.07.14 ABB (Asea Brown Boveri) Neutral JP Morgan Chase & Co.
23.07.14 ABB (Asea Brown Boveri) buy S&P Capital IQ
23.07.14 Holcim overweight JP Morgan Chase & Co.
23.07.14 Holcim overweight JP Morgan Chase & Co.
23.07.14 UBS buy UBS AG
23.07.14 UBS Hold Kelper Cheuvreux
23.07.14 UBS Underweight JP Morgan Chase & Co.
22.07.14 UBS buy S&P Capital IQ
22.07.14 UBS Hold Société Générale Group S.A. (SG)
22.07.14 UBS neutral Independent Research GmbH
22.07.14 UBS buy Jefferies & Company Inc.
22.07.14 UBS buy UBS AG
21.07.14 Novartis Underweight Morgan Stanley
21.07.14 Novartis Equal weight Barclays Capital
21.07.14 UBS buy Citigroup Corp.
21.07.14 UBS buy Citigroup Corp.
21.07.14 Novartis overweight JP Morgan Chase & Co.
18.07.14 Givaudan Outperform Credit Suisse Group
18.07.14 Givaudan Sell Goldman Sachs Group Inc.
18.07.14 UBS overweight JP Morgan Chase & Co.
18.07.14 UBS buy Goldman Sachs Group Inc.
18.07.14 UBS Conviction Buy Goldman Sachs Group Inc.
18.07.14 Roche Conviction Buy Goldman Sachs Group Inc.
17.07.14 Roche buy UBS AG
17.07.14 UBS buy UBS AG
17.07.14 Roche overweight Morgan Stanley
17.07.14 Novartis buy S&P Capital IQ
17.07.14 Nestlé overweight JP Morgan Chase & Co.
17.07.14 Holcim buy UBS AG
17.07.14 Holcim buy UBS AG
16.07.14 Givaudan buy Nomura
15.07.14 Roche Conviction Buy List Goldman Sachs Group Inc.
15.07.14 Novartis Neutral Goldman Sachs Group Inc.
14.07.14 Novartis buy UBS AG
14.07.14 UBS buy Deutsche Bank AG
14.07.14 UBS buy Deutsche Bank AG
14.07.14 Novartis buy Jefferies & Company Inc.
14.07.14 Novartis buy Jefferies & Company Inc.
14.07.14 UBS overweight HSBC
11.07.14 Nestlé buy Citigroup Corp.